African self-sufficiency in cancer control
Document Type
Article
Department
General Surgery (East Africa)
Abstract
Africa’s heavy reliance on imported pharmaceuticals—up to 90% in many countries—left oncology services vulnerable during the COVID-19 pandemic and highlights the risks of dependency on foreign aid. While local pharmaceutical production is viable, most facilities operate below global efficiency levels, and production remains concentrated in a few nations. Regional harmonization of procurement, protocols, and training is essential to achieving economies of scale and reducing system fragmentation. Organizations like the African Organisation for Research and Training in Cancer (AORTIC) demonstrate the power of Pan-African collaboration. Sustainable cancer care in Africa requires systems that are locally driven and resilient, with international partners playing a supporting—not substitutive—role. The commentary advocates for a future where Africa leads its path toward cancer control and health sovereignty.
Publication (Name of Journal)
The Lancet Oncology
DOI
https://doi.org/10.1016/S1470-2045(25)00369-9
Recommended Citation
Tawfiles, D.,
Bounedjar, A.,
Alatise, O. I.,
Kingham, P.,
Balogun, O.,
Mutebi, M.,
Dee, E. C.
(2025). African self-sufficiency in cancer control. The Lancet Oncology, 26(7), 1.
Available at:
https://ecommons.aku.edu/eastafrica_fhs_mc_gen_surg/145